ProQR, Galapagos in oligonucleotide deal for fibrosis

ProQR Therapeutics N.V. (NASDAQ:PRQR) and Galapagos N.V. (Euronext:GLPG; NASDAQ:GLPG) partnered

Read the full 107 word article

User Sign In